Medicare Enrolled

Dr. Santosh Nair, MD

Optician · Orange City, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
2776 ENTERPRISE ROAD, Orange City, FL 32763
3867741223
In practice since 2006 (19 years)
NPI: 1982653713 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nair from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nair? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nair

Dr. Santosh Nair is an optician in Orange City, FL, with 19 years in practice. Based on federal Medicare data, Dr. Nair performed 72,481 Medicare services across 3,733 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nair received a total of $45,599 from 30 pharmaceutical and/or device companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nair is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in FL$ $45,599 industry payments

Medicare Practice Summary

Medicare Utilization ↗
72,481
Medicare services
Top 1% in FL for optician
3,733
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,815 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)27,037$0$2
Iron sucrose injection (Venofer)18,202$0$1
Pembrolizumab injection (Keytruda)9,002$43$120
Contrast dye for imaging (iodine-based)4,500$0$0
Denosumab injection (Prolia/Xgeva)3,841$18$43
Dexamethasone injection (steroid)1,250$0$1
Complete blood count (CBC) with differential1,001$8$18
Blood draw (venipuncture)805$4$4
Anti-nausea injection (Aloxi/palonosetron)801$1$20
Office visit, established patient (20-29 min)719$65$219
Comprehensive metabolic blood panel645$10$29
Phosphate level test563$5$15
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less276$22$60
Drug injection, under skin or into muscle269$11$76
Ferritin level test (iron stores)240$13$39
Iron level test240$6$18
Iron binding capacity test238$9$24
Vitamin B-12 level test237$15$43
Folic acid level test237$14$42
Administration of chemotherapy into vein, 1 hour or less219$98$415
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less164$47$117
Initial hospital admission, high complexity162$137$605
Hospital follow-up visit, moderate complexity159$62$213
Injection of drug or substance into vein139$28$92
Hospital follow-up visit, high complexity137$94$307
Administration of chemotherapy into vein, each additional hour110$22$90
Injection of additional new drug or substance into vein109$12$41
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-396$20$58
Injection, diphenhydramine hcl, up to 50 mg80$1$2
Lactate dehydrogenase (enzyme) level77$6$16
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries75$402$560
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg70$1$5
Nuclear medicine study from skull base to mid-thigh with ct scan68$1,098$3,475
Infusion into a vein for hydration, each additional hour68$10$30
Carcinoembryonic antigen (cea) protein level55$19$49
Prothrombin time test (blood clotting)55$4$15
Ct scan of chest with contrast54$83$979
Administration of additional new drug or substance into vein, 1 hour or less54$49$160
Office visit, established patient (30-39 min)52$97$321
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional51$15$60
Irrigation of implanted venous access drug delivery device46$18$55
Thyroid stimulating hormone (TSH) test42$16$57
New patient office visit (30-44 min)40$87$327
Infusion into a vein for hydration, 31-60 minutes38$24$97
Infusion, normal saline solution , 1000 cc37$2$6
CT scan of abdomen and pelvis with contrast36$171$987
Magnesium level test32$7$18
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle30$52$123
Cystatin c (enzyme inhibitor) level23$18$37
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
38.1% high complexity
53.5% medium
8.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$45,599
Total received (2018-2024)
Avg $6,514/year across 7 years
Top 4% in FL for optician
30
Companies
137
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,409 (49.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,360 (44.6%)
Other
Charitable contributions, space rental, and other categories
$1,522 (3.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,308 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19
2023
$830
2022
$557
2021
$1,210
2020
$321
2019
$28,712
2018
$13,950

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tosoh Bioscience, Inc.
$12,340
Amgen Inc.
$8,758
Celgene Corporation
$6,911
AstraZeneca Pharmaceuticals LP
$3,446
Spectrum Pharmaceuticals Inc.
$2,620
Novartis Pharmaceuticals Corporation
$2,270
Merck Sharp & Dohme Corporation
$2,041
AstraZeneca UK Limited
$1,698
Secura Bio, Inc.
$1,200
Daiichi Sankyo Inc.
$770
Foundation Medicine, Inc.
$536
ASD Specialty Healthcare, LLC
$413
Heron Therapeutics, Inc.
$368
Janssen Scientific Affairs, LLC
$356
Ipsen Biopharmaceuticals, Inc
$307
E.R. Squibb & Sons, L.L.C.
$252
Bayer HealthCare Pharmaceuticals Inc.
$238
Cardinal Health 108, LLC
$194
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Exelixis Inc.
$147
TESARO, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$124
Janssen Biotech, Inc.
$99
GENZYME CORPORATION
$62
SUN PHARMACEUTICAL INDUSTRIES INC.
$56
ABBVIE INC.
$36
Kite Pharma, Inc.
$33
Agios Pharmaceuticals, Inc.
$22
Janssen Pharmaceuticals, Inc
$9
PFIZER INC.
$1
Top 3 companies account for 61.4% of total payments
Associated products mentioned in payments ›
AIA-PACK Calibrator Set · Aliqopa · B12 · CALQUENCE · CINVANTI · Cabometyx · Cystatin C · DARZALEX · ENHERTU · Enhertu · FARYDAK · FASLODEX · FOUNDATIONACT · FOUNDATIONONE · IBRANCE · IMBRUVICA · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LUMAKRAS · Luspatercept · MK-7339 · NINLARO · Neulasta · OPDIVO · PA · PROMACTA · SOMATULINE DEPOT · ST AIA-PACK · ST AIA-PACK Cystatin C Calibrator Set · SUSTOL · Somatuline Depot · TABRECTA · TIBSOVO · TSH3G · VENCLEXTA · XARELTO · YONSA · Yescarta · ZEJULA · ZYTIGA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (49%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for optician in FL.

Equivalent to $63 per 100 Medicare services performed
Looking for a optician in Orange City?
Compare opticians in the Orange City area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
213
Per 100K population
37.5
County median income
$66,581
Nearest hospital
ADVENTHEALTH FISH MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nair is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (consulting-driven, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nair experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Nair performed 27,037 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nair receive payments from pharmaceutical companies?
Yes. Dr. Nair received a total of $45,599 from 30 companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nair's costs compare to other opticians in Orange City?
Dr. Nair's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nair) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →